Ben S. Cooper

Active 1967–2025

84
Papers
27,380
Citations
52
h-index
81
i10-index

Citations

Citations per year for Ben S. Cooper1976: 1 citations1979: 1 citations1980: 1 citations1983: 1 citations1986: 2 citations1992: 1 citations1997: 2 citations1998: 1 citations1999: 4 citations2000: 4 citations2001: 7 citations2002: 8 citations2003: 25 citations2004: 57 citations2005: 60 citations2006: 97 citations2007: 97 citations2008: 61 citations2009: 71 citations2010: 94 citations2011: 120 citations2012: 82 citations2013: 130 citations2014: 103 citations2015: 102 citations2016: 74 citations2017: 101 citations2018: 76 citations2019: 229 citations2020: 488 citations2021: 315 citations2022: 828 citations2023: 1,247 citations2024: 2,295 citations2025: 1,173 citations2026: 26 citations1977–1978: no citations, so these years are not shown1981–1982: no citations, so these years are not shown1984–1985: no citations, so these years are not shown1987–1991: no citations, so these years are not shown1993–1996: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,033 citing papers, 13.8% of this breakdownUnited Kingdom: 1,455 citing papers, 9.9% of this breakdownChina: 1,231 citing papers, 8.4% of this breakdownGermany: 534 citing papers, 3.6% of this breakdownAustralia: 519 citing papers, 3.5% of this breakdownFrance: 518 citing papers, 3.5% of this breakdownIndia: 497 citing papers, 3.4% of this breakdownCanada: 463 citing papers, 3.2% of this breakdownItaly: 452 citing papers, 3.1% of this breakdownSwitzerland: 416 citing papers, 2.8% of this breakdownSpain: 408 citing papers, 2.8% of this breakdownNetherlands: 368 citing papers, 2.5% of this breakdown
0%13.8%Other 39.5%

Fields

  • Medicine28%
  • Biochemistry, Genetics and Molecular Biology26.9%
  • Immunology and Microbiology17.1%
  • Environmental Science8.6%
  • Mathematics6.2%
  • Agricultural and Biological Sciences3.1%
  • Other10.1%

Topics

  • Antibiotic Resistance in Bacteria10.9%
  • Antibiotic Use and Resistance8%
  • Pharmaceutical and Antibiotic Environmental Impacts3.6%
  • Bacterial Identification and Susceptibility Testing3.3%
  • COVID-19 epidemiological studies3.1%
  • Antimicrobial Resistance in Staphylococcus2.5%
  • Other68.6%

Coauthors

All papers

Open in search
  1. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Buddha Basnyat, Adrie Bekker, Rose Bender, James A. Berkley, B. Adhisivam, Julia Bielicki, Suppawat Boonkasidecha, James Bukosia, Cristina Gardonyi Carvalheiro, Carlos A Castañeda-Orjuela, Vilada Chansamouth, Suman Chaurasia, Sara Chiurchiù, Fazle Rabbi Chowdhury, Rafai Clotaire Donatien, Aislinn Cook, Ben S. Cooper, Tim R. Cressey, Elia Criollo-Mora, Matthew Cunningham, Saffiatou Darboe, Nicholas Day, Maia De Luca, Клара Докова, Angela Dramowski, Susanna Dunachie, Thuy Duong Bich, Tim Eckmanns, Daniel Eibach, Amir Emami, Nicholas Feasey, Natasha Fisher-Pearson, Karen Forrest, Coralith Garcia, Denise O. Garrett, Petra Gastmeier, Ababi Zergaw Giref, Rachel Greer, Vikas Gupta, Sebastian Haller, Andrea Haselbeck, Simon I Hay, Marianne Holm, Susan Hopkins, Yingfen Hsia, Kenneth Iregbu, Jan Jacobs, Daniel Jarovsky, Fatemeh Javanmardi, Adam Jenney, Meera Khorana, Suwimon Khusuwan, Niranjan Kissoon, Elsa Kobeissi, Tomislav Kostyanev, Fiorella Krapp, Ralf Krumkamp, Ajay Kumar, Hmwe Hmwe Kyu, Cherry Lim, Kruy Lim, Direk Limmathurotsakul, Michael J. Loftus, Miles Lunn, Jianing Ma, Anand Manoharan, Florian Marks, Jürgen May, Mayfong Mayxay, Neema Mturi and 75 more - The Lancet 2022 cited by 15,473

  2. Global burden associated with 85 pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jonathan F Mosser, Vincent Mougin, Pirouz Naghavi, Amanda Novotney, Víctor Rosenthal, Benn Sartorius, Andy Stergachis, Christopher Troeger, Avina Vongpradith, Magdalene K Walters, Han Yong Wunrow, Christopher J L Murray - The Lancet Infectious Diseases 2024 cited by 264

  3. Enumerating the economic cost of antimicrobial resistance per antibiotic consumed to inform the evaluation of interventions affecting their use

    Authors: , , , , , , , , , - Antimicrobial Resistance and Infection Control 2018 cited by 291

  4. Pervasive transmission of a carbapenem resistance plasmid in the gut microbiota of hospitalized patients

    Authors: , , , , , , , , , , , , , - Nature Microbiology 2021 cited by 188

  5. Using machine learning to guide targeted and locally-tailored empiric antibiotic prescribing in a children's hospital in Cambodia

    Authors: , , , , , , , , - Wellcome Open Research 2018 cited by 91

  6. A current perspective on antimicrobial resistance in Southeast Asia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Paul N. Newton, Daniel H. Paris, Nicholas R. Thomson, Paul Turner, Oralak Serichantalergs, Frank Smithuis, Vanaporn Wuthiekanun, Nicholas J. White, Hsu Li Yang - Journal of Antimicrobial Chemotherapy 2017 cited by 214

  7. Transmission Dynamics and Control of Severe Acute Respiratory Syndrome

    Authors: , , , , , , , , , , , - Science 2003 cited by 1,604

  8. Positive selection and compensatory adaptation interact to stabilize non-transmissible plasmids

    Authors: , , , , , , - Nature Communications 2014 cited by 289

  9. Decontamination Strategies and Bloodstream Infections With Antibiotic-Resistant Microorganisms in Ventilated Patients

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Giuseppe Nardi, Christian Brun‐Buisson, Marc J. M. Bonten - JAMA 2018 cited by 184

  10. Antimicrobial resistance prevalence in bloodstream infection in 29 European countries by age and sex: An observational study

    Authors: , , , - PLoS Medicine 2024 cited by 62

  11. Individualised, short-course antibiotic treatment versus usual long-course treatment for ventilator-associated pneumonia (REGARD-VAP): a multicentre, individually randomised, open-label, non-inferiority trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Arthitpong Narmwong, Chaianan Sodapak, Somboon Nuntalohit, Somsamai Boonsong, Jiraphorn Nilsakul, Jirawat Moolasart, Anakapong Phunmanee, Anupol Panitchote, Pichayen Duangthongphon, Pornrith Pisuttimarn, Nuttiya Srisurat, Hwee Seng Yip, Graeme MacLaren, Wei Lim Toon, Ka Lip Chew, Shir Lynn Lim, Boon Wee Teo, Tian Jin Lim, Louisa Sun, Siyu Peng, Nicholas Graves, Yin Tze Chew, Li Min Ling, Po Ying Chia, Yew Woon Chia, Wenjie Huang, Yu Kit Chan, Roshan Piya, Anil Shrestha, Abhilasha Karkey, Sabina Dongol, Felipe Francisco Tuon - The Lancet Respiratory Medicine 2024 cited by 62

  12. A scoping review of antibiotic use practices and drivers of inappropriate antibiotic use in animal farms in WHO Southeast Asia region

    Authors: , , , , , , , , , - One Health 2022 cited by 46

  13. The uncertain role of substandard and falsified medicines in the emergence and spread of antimicrobial resistance

    Authors: , , , , , , , , , - Nature Communications 2023 cited by 41

  14. Implications of reducing antibiotic treatment duration for antimicrobial resistance in hospital settings: A modelling study and meta-analysis

    Authors: , , , , - PLoS Medicine 2023 cited by 48

  15. Decontamination of the Digestive Tract and Oropharynx in ICU Patients

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jan P. Arends, Leon Aarts, Patrick Sturm, H.I.J. Harinck, A. Voss, Esther V. Uijtendaal, Hetty E. M. Blok, Emily S. Thieme Groen, M. E. Pouw, Cor J. Kalkman, Marc J. M. Bonten - New England Journal of Medicine 2008 cited by 823

  16. Multiplex PCR point of care testing versus routine, laboratory-based testing in the treatment of adults with respiratory tract infections: a quasi-randomised study assessing impact on length of stay and antimicrobial use

    Authors: , , , , , , , , - BMC Infectious Diseases 2017 cited by 119

  17. Impact of low blood culture usage on rates of antimicrobial resistance

    Authors: , , , , , , , , , , - Journal of Infection 2020 cited by 35

  18. Interventions to reduce colonisation and transmission of antimicrobial-resistant bacteria in intensive care units: an interrupted time series study and cluster randomised trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , - The Lancet Infectious Diseases 2013 cited by 354

  19. Comparative efficacy of interventions to promote hand hygiene in hospital: systematic review and network meta-analysis

    Authors: , , , , , , , , - BMJ 2015 cited by 328

  20. Expression of resistance to tetracyclines in strains of methicillin-resistant Staphylococcus aureus

    Authors: , , , - Journal of Antimicrobial Chemotherapy 2000 cited by 276

  21. The burden and dynamics of hospital-acquired SARS-CoV-2 in England

    Authors: , , , , , , , , , , , , , , , , , - Nature 2023 cited by 54

  22. The ORION statement: guidelines for transparent reporting of Outbreak Reports and Intervention studies Of Nosocomial infection

    Authors: , , , , , , , , , , , - Journal of Antimicrobial Chemotherapy 2007 cited by 313

  23. Microbiology Investigation Criteria for Reporting Objectively (MICRO): a framework for the reporting and interpretation of clinical microbiology data

    Authors: , , , , , , , , , , , , , , , , , - BMC Medicine 2019 cited by 105

  24. Contact isolation versus standard precautions to decrease acquisition of extended-spectrum β-lactamase-producing Enterobacterales in non-critical care wards: a cluster-randomised crossover trial

    Authors: , , , , , , , , , , , , , , , , , , - The Lancet Infectious Diseases 2020 cited by 79